FREE CASE EVALUATION: CALL 1-800-632-1404
Wrong Low T Therapy Treatment Widespread, Users at 30 Percent Higher Risk of Heart Attack
Two recent studies have highlighted that the use of inappropriate testosterone therapy among U.S. men puts them at a greater risk of cardiovascular diseases, including heart attack. According to the Journal of Clinical Endocrinology & Metabolism, while the number of testosterone therapy users has registered a five-fold rise in the United States, only a small percentage of them adhere to appropriate testing and user guidelines. Published in January 2014, the report highlights that a vast majority of them are receiving the Low T supplements without any test or even after have been tested with normal testosterone levels.
Researchers hold that aggressive and direct-to-consumer marketing by manufacturers of testosterone supplements, such as AndroGel, Androderm, Testim, and others, was responsible for large-scale inappropriate use by men. Advertisements focus on encouraging men to go for Low T medications to increase their muscles, sexual ability, and energy level. Hypogonadism or testosterone deficiency, for which the supplements are available, is no more a condition for the treatment.
The study found that the abuse was more prevalent in the United States despite a severe risk of testosterone therapy cardiovascular side effects. The enthusiasm to increase libido and strength pushes them to “initiate the testosterone therapy at normal levels and many even initiate it without recent testing,” researchers claim.
30 Percent Increase in Fatal Heart Attack Risk
Testosterone therapy may cause serious and fatal cardiovascular side effects. The testosterone therapy heart attack risk leading to stroke and death is as high as 30 percent when compared to those not using Low T supplements, the Journal of the American Medical Association reported in November 2013. Based on a study of ex-servicemen registered with the Eastern Colorado Health Care System, it found nearly 30 percent greater risk of serious and fatal heart problems linked to testosterone therapy. We expect that scientists will continue to link Low T therapy with cardiovascular injuries.
According to the JAMA report, Low T supplements play a role in increasing cardiovascular disorders risk of heart attack, stroke, and death. Of 8,700 men with low level of testosterone and coronary angiography studied, 1,223 received supplements to boost their testosterone production. Doctors discovered that 26 percent of those treated with the Low T supplements had suffered a stroke or heart attack, with a few deaths, within three years. The rate of same events among the non-testosterone group was less than 20 percent. It was found that those treated with testosterone therapy faced a higher risk of cardiovascular disorder despite being younger and with very few health disorders.
FDA Advises Against “Age-Related” Testosterone Therapy Solution
According to the FDA guidelines, men should not use testosterone therapy to prevent normal reduction in hormone production with age. Low T solutions are only for those suffering from hypogonadism, a medical conditions that results in testosterone deficiency. The Endocrine Society has also advised against use of testosterone supplements without proper clinical diagnosis and abnormal reduction in testosterone levels. The fatal side effects of Low T supplements play a crucial role in the publication of such suggestions. We recommend you, of course, consult with your doctor about whether to undergo a Low T program.
However, contrary to all these warnings, manufacturers continue to promote the Low T supplements through direct-to-consumer ads, a key factor in men using testosterone therapy on their own and facing fatal side effects.
If you or a loved one have experienced a testosterone replacement therapy injury after undergoing low testosterone therapy, please contact our team of lawyers today for a free case evaluation at:
CALL: 1-800-632-1404
FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:
NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming